Dulera
formulated to manage asthma to alleviate respiratory distress.
Strengths: 6/200mcg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Fostair; Symbicort
- Therapeutic class
Inhaled Corticosteroid; Long-acting Beta2-agonist
- Pharmacological class
Corticosteroid; Beta2-adrenoceptor agonist
- Minor side effects
headache; nasopharyngitis; sinusitis
- Moderate side effects
oral candidiasis; tremor
- Dosage forms
Inhalation powder
- Administration route
Inhalation use
- Patient summary
formulated to manage asthma to alleviate respiratory distress.
- Prescription status
POM
- Manufacturer
Merck & Co
- Onset Time
5–15 minutes
- Duration
12 hours
- Storage instructions
Store below 30°C. Keep inhaler protected from moisture.
- Drug interactions
beta-blockers; cytochrome p450 inhibitors
Contraindications
hypersensitivity to corticosteroids; hypersensitivity to formoterol; acute asthma attack
Precautions and warnings
rinse mouth after use to prevent oral candida; monitor for systemic corticosteroid effects; use with care in patients with cardiac disorders
Serious side effects
paradoxical bronchospasm — requires immediate medical attention; anaphylactic reactions — requires immediate medical attention
Mechanism of action
This combination contains an inhaled corticosteroid that reduces airway inflammation and a long-acting beta2-agonist that dilates the bronchial passages, facilitating easier airflow to the lungs.
Pregnancy and breastfeeding
Pregnancy: use only if clearly necessary. Breastfeeding: caution advised; consult a specialist.
Dulera
formulated to manage asthma to alleviate respiratory distress.
Editorial Notes
- Active ingredient(s): Mometasone, Formoterol
- Listed indication(s): Asthma
Available option
- 2 inhalers - 6/200 mcg1491-6-200-mcg-17845